Orgenesis ORGS Stock
Orgenesis Price Chart
Orgenesis ORGS Financial and Trading Overview
| Orgenesis stock price | 0.1 USD |
| Previous Close | 0.03 USD |
| Open | 0.91 USD |
| Bid | 1.11 USD x 52200 |
| Ask | 1.15 USD x 15200 |
| Day's Range | 0.91 - 0.91 USD |
| 52 Week Range | 0.001 - 1 USD |
| Volume | 100 USD |
| Avg. Volume | 415 USD |
| Market Cap | 979.95K USD |
| Beta (5Y Monthly) | 3.349 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.94 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ORGS Valuation Measures
| Enterprise Value | 18.04M USD |
| Trailing P/E | N/A |
| Forward P/E | 0.16393442 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9468145 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 17.431 |
| Enterprise Value/EBITDA | -0.754 |
Trading Information
Orgenesis Stock Price History
| Beta (5Y Monthly) | 3.349 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 18.67% |
| 52 Week High | 1 USD |
| 52 Week Low | 0.001 USD |
| 50-Day Moving Average | 0.32 USD |
| 200-Day Moving Average | 0.37 USD |
ORGS Share Statistics
| Avg. Volume (3 month) | 415 USD |
| Avg. Daily Volume (10-Days) | 370 USD |
| Shares Outstanding | 9.8M |
| Float | 3.64M |
| Short Ratio | 2.39 |
| % Held by Insiders | 46.42% |
| % Held by Institutions | 0.51% |
| Shares Short | 56.25K |
| Short % of Float | 1.33% |
| Short % of Shares Outstanding | 1.17% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2024 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2196.25% |
| Gross Margin | -86.28% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -204.48% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.04M USD |
| Revenue Per Share (ttm) | 0.25 USD |
| Quarterly Revenue Growth (yoy) | 215.49% |
| Gross Profit (ttm) | -893000 USD |
| EBITDA | -23929000 USD |
| Net Income Avi to Common (ttm) | -48165000 USD |
| Diluted EPS (ttm) | -11.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 204K USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 17.3M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.028 |
| Book Value Per Share (mrq) | -7.252 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17076000 USD |
| Levered Free Cash Flow (ttm) | -5432000 USD |
Profile of Orgenesis
| Country | United States |
| State | MD |
| City | Germantown |
| Address | 20271 Goldenrod Lane |
| ZIP | 20876 |
| Phone | 480 659 6404 |
| Website | https://orgenesis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 77 |
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.
Q&A For Orgenesis Stock
What is a current ORGS stock price?
Orgenesis ORGS stock price today per share is 0.1 USD.
How to purchase Orgenesis stock?
You can buy ORGS shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orgenesis?
The stock symbol or ticker of Orgenesis is ORGS.
Which industry does the Orgenesis company belong to?
The Orgenesis industry is Biotechnology.
How many shares does Orgenesis have in circulation?
The max supply of Orgenesis shares is 9.8M.
What is Orgenesis Price to Earnings Ratio (PE Ratio)?
Orgenesis PE Ratio is now.
What was Orgenesis earnings per share over the trailing 12 months (TTM)?
Orgenesis EPS is -1.94 USD over the trailing 12 months.
Which sector does the Orgenesis company belong to?
The Orgenesis sector is Healthcare.
Orgenesis ORGS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26096.88 USD — |
+0.45
|
5.2B USD — | 26034.35 USD — | 26225.83 USD — | — - | 5.2B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
144.46 USD — |
+1.35
|
— — | 143.15 USD — | 144.82 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1376.15 USD — |
+1.09
|
— — | 1366.6 USD — | 1381.83 USD — | — - | — — |
- {{ link.label }} {{link}}
